1066 Share Price

Open 5.20 Change Price %
High 5.33 1 Day 0.00 0.00
Low 5.20 1 Week 0.12 2.33
Close 5.28 1 Month 0.23 4.55
Volume 4015347 1 Year 0.58 12.34
52 Week High 5.67
52 Week Low 4.22
1066 Important Levels
Resistance 2 5.40
Resistance 1 5.35
Pivot 5.27
Support 1 5.21
Support 2 5.16
HKG HongKong Most Active Stocks
0364 0.03 -25.00%
0136 0.20 -20.00%
0566 3.91 0.00%
0061 0.02 0.00%
3988 3.51 -1.13%
0939 5.79 -1.03%
0381 0.08 0.00%
1076 0.15 0.00%
0030 0.15 7.14%
0261 0.01 0.00%
More..
HKG HongKong Top Gainers Stocks
2168 4.60 17.65%
0582 0.07 16.67%
8129 0.08 14.29%
0621 0.09 12.50%
2302 2.87 11.67%
2882 0.10 11.11%
8163 0.10 11.11%
3318 2.12 10.42%
8321 9.40 10.33%
8088 0.11 10.00%
More..
HKG HongKong Top Losers Stocks
4338 80.00 -38.93%
4333 60.00 -25.00%
0364 0.03 -25.00%
0136 0.20 -20.00%
8351 0.10 -16.67%
8272 0.05 -16.67%
8002 4.00 -15.97%
8201 0.07 -12.50%
8262 0.89 -11.88%
0193 0.08 -11.11%
More..

Shandong Weigao Group (HKG: 1066)

1066 Technical Analysis 4
As on 20th Jan 2017 1066 Share Price closed @ 5.28 and we RECOMMEND Buy for LONG-TERM with Stoploss of 4.90 & Strong Buy for SHORT-TERM with Stoploss of 5.14 we also expect STOCK to react on Following IMPORTANT LEVELS.
1066 Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
1066 Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.weigaogroup.com
1066 Address
1066
No.18 Xinshan Road
Torch Hi-Tech Industry Development Zone
Weihai, 264210
China
Phone: 86 63 1562 1999
Fax: 86 63 1562 1999
1066 Latest News
North America Disposable Plastic Blood Bag Market is Expected to Witness ...   IT Business Net   - 05th Jan 17
TriReme Medical Signs Agreement With HealthTrust To Broaden Hospital Access To ...   PR Newswire (press release)   - 20th Dec 16
Analysis: Weigao Ortho reveals backdoor listing plans   HealthInvestor Asia   - 15th Jun 16
Welcome to China's $1 Trillion Club. Now for the Hard Part   Bloomberg   - 09th Jun 16
Stock Update (NASDAQ:AMDA): Amedica Corporation Signs Exclusive Chinese ...   Smarter Analyst   - 18th Apr 16
Med Device Biz To Go Private In $812M Citic Deal   Law360 (subscription)   - 05th Nov 15
China Pharmaceutical Glass Packaging Industry Report, 2014-2017   PR Newswire (press release)   - 03rd Jun 15
China Orthopedic Instrument Industry Report, 2014-2017   PR Newswire (press release)   - 21st May 15
Shandong Weigao Inks $312M Deal To Sell Biosensors Stake   Law360 (subscription)   - 23rd Nov 13
Weigao Group to sell entire stake in Biosensors   Venture Capital Post   - 22nd Nov 13
Interactive Technical Analysis Chart Shandong Weigao Group ( 1066 HKG HongKong )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Shandong Weigao Group
1066 Business Profile
Shandong Weigao Group Medical Polymer Company Limited is engaged in the research and development, production, and sale of medical devices under the Jierui and Wego Ortho brands in the People’s Republic of China and internationally. The company operates through Single Use Medical Device Products, Orthopaedic Products, and Blood Purification Products divisions. It offers single use medical consumables and materials, which include infusion sets, syringes, blood bags and blood component segregator consumables, blood sampling consumables, pre-filled syringes, dental consumables, anesthetic consumables, and medical PVC granules and non-PVC granules, as well as medical needle products comprising intravenous, syringe, intravenous catheter, blood sampling, and irregular needles. The company also provides orthopaedic materials and tools comprising therapeutic consumables, such as steel plates, screws, spinal series consumables, and artificial joints consumables. In addition, it offers blood purification consumables, including renal consumables, such as puncture needles, blood circuits, dialysis equipment, and immunity adsorption products for the treatment of immune system diseases; and other LDL adsorption, internal toxin adsorption, and hepatitis B adsorption products, as well as heart eluting stents, including drug eluting stents and balloon catheters. Further, the company is involved in trading medical products; providing logistics and storage services; and manufacturing moulds, and industrial automatic equipment and parts, as well as provides medical management software development and related technical consulting services. It sells its products to healthcare organizations and distributors, including hospitals, blood stations, and other medical units. The company was founded in 2000 and is based in Weihai, the People’s Republic of China. Shandong Weigao Group Medical Polymer Company Limited is a subsidiary of Weigao Holding Company Limited.